Insufficient thyroid activity during pregnancy is harmful to maternal and fetal health as well as to the child’s future intellectual development, according to emerging data that led to new guidelines released by the American Thyroid Association (ATA). These guidelines highlight the role of thyroid function tests, hypothyroidism, thyrotoxicosis, iodine, thyroid antibodies and miscarriage or preterm delivery, thyroid nodules and cancer, postpartum thyroiditis, screening recommendations during pregnancy, and areas for future research.
Insufficient thyroid activity during pregnancy is harmful to maternal and fetal health as well as to the child’s future intellectual development, according to emerging data that led to new guidelines released by the American Thyroid Association (ATA).1 These guidelines highlight the role of thyroid function tests, hypothyroidism, thyrotoxicosis, iodine, thyroid antibodies and miscarriage or preterm delivery, thyroid nodules and cancer, postpartum thyroiditis, screening recommendations during pregnancy, and areas for future research.
The production of thyroid hormones and the body’s iodine requirements each increase by about 50% during pregnancy. Subsequently, the thyroid gland can enlarge by 10% in countries where iodine sources are sufficient and up to 20% to 40% in countries where there is iodine deficiency.1 According to the members of the ATA Taskforce, “Pregnancy has a profound impact on the thyroid gland and thyroid function. . . . In essence, pregnancy is a stress test for the thyroid, resulting in hypothyroidism in women with limited thyroidal reserve or iodine deficiency.”1
Subclinical thyroid disease and overt hypothyroidism and hyperthyroidism in pregnant women can have harmful effects. An extreme form of neurological damage caused by neonatal hypothyroidism that goes untreated is cretinism, which is characterized by gross mental retardation along with varying degrees of short stature, deaf mutism, and spasticity. There is also some evidence of an association between miscarriage and preterm delivery in women with normal thyroid function who test positive for thyroid peroxidase (TPO) antibodies; the strength of this association is being further studied.
The ATA issued 76 specific recommendations that cover the diagnosis and management of thyroid disease during pregnancy and the postpartum period. Examples of these guidelines include the following:
• Women with overt hypothyroidism or with subclinical hypothyroidism who test positive for TPO antibodies should be treated with oral levothyroxine.
• Use of other thyroid preparations, such as triiodothyronine or desiccated thyroid, to treat maternal hypothyroidism is strongly discouraged.
• Women with subclinical hypothyroidism in pregnancy who are not initially treated should be monitored for progression to overt hypothyroidism with serum thyroid-stimulating hormone and free thyroxine measurements every 4 weeks until 16 to 20 weeks gestation and at least once between 26 and 32 weeks gestation.
More Information
National Endocrine and Metabolic Diseases Information Service: Pregnancy and Thyroid DiseaseAutoimmune Thyroid Disease and Pregnancy
Related Content
Educational Tutorial: Medical Complication in Pregnancy – Thyroid Disease
Educational Tutorial: Thyroid Disease in Pregnancy
Reference
1. Stagnaro-Green A, Abalovich M, Alexander E, et al, for the American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10). Epub ahead of print.
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More